AEMD Stock Overview
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Aethlon Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.48 |
| 52 Week High | US$5.00 |
| 52 Week Low | US$1.35 |
| Beta | 1.94 |
| 1 Month Change | -13.45% |
| 3 Month Change | -22.51% |
| 1 Year Change | -67.11% |
| 3 Year Change | -92.29% |
| 5 Year Change | -98.70% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate
Aug 02
FDA approves protocol change in Aethlon's trial of its purifier to treat severe COVID
Jul 11We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate
Mar 18We're Interested To See How Aethlon Medical (NASDAQ:AEMD) Uses Its Cash Hoard To Grow
Nov 09Aethlon Medical climbs on Reddit interest
Jun 09We're Keeping An Eye On Aethlon Medical's (NASDAQ:AEMD) Cash Burn Rate
May 12We're Hopeful That Aethlon Medical (NASDAQ:AEMD) Will Use Its Cash Wisely
Jan 27Aethlon Medical has a new business and medical chief
Jan 06Aethlon Medical (AEMD) rockets 63% as FDA amends Hemopurifier IDE for COVID-10 treatment
Dec 16Aethlon names Charles J. Fisher, Jr., M.D. as CEO
Nov 03Shareholder Returns
| AEMD | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 2.8% | -2.9% | -3.2% |
| 1Y | -67.1% | -3.7% | 19.3% |
Return vs Industry: AEMD underperformed the US Medical Equipment industry which returned -3.7% over the past year.
Return vs Market: AEMD underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| AEMD volatility | |
|---|---|
| AEMD Average Weekly Movement | 5.1% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AEMD's share price has been volatile over the past 3 months.
Volatility Over Time: AEMD's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 15 | Jim Frakes | www.aethlonmedical.com |
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.
Aethlon Medical, Inc. Fundamentals Summary
| AEMD fundamental statistics | |
|---|---|
| Market cap | US$3.88m |
| Earnings (TTM) | -US$12.25m |
| Revenue (TTM) | US$574.25k |
6.8x
P/S Ratio-0.3x
P/E RatioIs AEMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AEMD income statement (TTM) | |
|---|---|
| Revenue | US$574.25k |
| Cost of Revenue | US$0 |
| Gross Profit | US$574.25k |
| Other Expenses | US$12.82m |
| Earnings | -US$12.25m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.67 |
| Gross Margin | 100.00% |
| Net Profit Margin | -2,133.18% |
| Debt/Equity Ratio | 0% |
How did AEMD perform over the long term?
See historical performance and comparison